Loading...
XSHE
000538
Market cap14bUSD
Dec 05, Last price  
55.93CNY
1D
0.36%
1Q
-5.68%
Jan 2017
-26.55%
Name

Yunnan Baiyao Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000538 chart
P/E
21.01
P/S
2.49
EPS
2.66
Div Yield, %
3.71%
Shrs. gr., 5y
Rev. gr., 5y
6.18%
Revenues
40.03b
+2.36%
2,448,395,0213,200,335,5134,115,716,8995,723,198,6677,171,784,04310,075,437,83411,312,322,43213,686,824,52515,814,790,88018,814,366,37220,738,126,20522,410,654,40424,314,614,04426,708,213,48729,664,673,86832,742,766,76336,373,919,01636,488,372,64939,111,292,15640,033,300,814
Net income
4.75b
+16.02%
230,370,274276,395,341336,790,481465,420,155603,719,565926,168,5801,210,908,6661,582,515,8432,321,453,7872,506,076,5012,770,841,4012,919,876,8123,144,981,4293,306,564,3174,183,727,5535,516,072,1782,804,916,7153,001,125,8874,093,782,0744,749,415,499
CFO
4.30b
+22.68%
286,277,104292,162,70060,503,123806,896,878460,548,807432,083,8840794,948,911341,641,5861,586,864,1792,179,500,4012,984,757,6821,155,689,9482,629,807,2362,104,744,8253,828,906,6325,223,278,2823,209,410,0323,502,742,3394,297,003,142
Dividend
May 10, 20242.077 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.
IPO date
Dec 15, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT